These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8754289)

  • 21. [Hypertension and insulin resistance].
    Voiculescu A; Kutkuhn B; Rösen P; Grabensee B
    Wien Klin Wochenschr; 1997 Oct; 109(19):758-66. PubMed ID: 9441522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Insulin resistance--possible causes and effects].
    Bornkessel B
    Med Monatsschr Pharm; 1996 Mar; 19(3):81-4. PubMed ID: 8868967
    [No Abstract]   [Full Text] [Related]  

  • 23. [Relationship between obesity, inflammation and insulin resistance: new concepts].
    Fève B; Bastard JP; Vidal H
    C R Biol; 2006 Aug; 329(8):587-97; discussion 653-5. PubMed ID: 16860277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of resistin in obesity, insulin resistance and Type II diabetes.
    Kusminski CM; McTernan PG; Kumar S
    Clin Sci (Lond); 2005 Sep; 109(3):243-56. PubMed ID: 16104844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National Diabetes Month. Spotlight on type 2 diabetes in kids.
    Dairman T
    Diabetes Self Manag; 2003; 20(6):25, 27. PubMed ID: 14971335
    [No Abstract]   [Full Text] [Related]  

  • 26. Obesity, inflammation, and insulin resistance--a mini-review.
    Zeyda M; Stulnig TM
    Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The deadly quartet--the insulin resistance syndrome.
    Opara JU; Levine JH
    South Med J; 1997 Dec; 90(12):1162-8. PubMed ID: 9404899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic basis of endocrine disease. 1. Molecular genetics of insulin resistant diabetes mellitus.
    Taylor SI; Cama A; Accili D; Barbetti F; Imano E; Kadowaki H; Kadowaki T
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1158-63. PubMed ID: 1955495
    [No Abstract]   [Full Text] [Related]  

  • 29. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans.
    Cruz PD; Hud JA
    J Invest Dermatol; 1992 Jun; 98(6 Suppl):82S-85S. PubMed ID: 1316928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acanthosis nigricans in obese patients: Presentations and implications for prevention of atherosclerotic vascular disease.
    Katz AS; Goff DC; Feldman SR
    Dermatol Online J; 2000 Sep; 6(1):1. PubMed ID: 11328611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The vascular trigger of type II diabetes mellitus.
    Lammert E
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S21-5. PubMed ID: 18777448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature.
    Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS
    Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Type 2 diabetes among adolescents in Israel].
    Pinhas-Hamiel O; Koren I; Vardi P
    Harefuah; 2000 Feb; 138(3):186-9, 271. PubMed ID: 10883089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.
    Fareau GG; Maldonado M; Oral E; Balasubramanyam A
    Metabolism; 2007 May; 56(5):670-5. PubMed ID: 17445543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relation of insulin resistance syndromes to risk of cardiovascular disease.
    Nesto RW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S11-8. PubMed ID: 14668699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity: the two faces of fat.
    Powell K
    Nature; 2007 May; 447(7144):525-7. PubMed ID: 17538594
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin resistance and pancreatic beta cell failure.
    Kasuga M
    J Clin Invest; 2006 Jul; 116(7):1756-60. PubMed ID: 16823472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance, acanthosis nigricans, and hypertriglyceridemia.
    Eberting CL; Javor E; Gorden P; Turner ML; Cowen EW
    J Am Acad Dermatol; 2005 Feb; 52(2):341-4. PubMed ID: 15692481
    [No Abstract]   [Full Text] [Related]  

  • 39. The application of bioengineering of acupuncture to the treatment of diabetes, insulin resistance and obesity.
    Litscher G
    Diabetes Obes Metab; 2010 Jul; 12(7):553-4. PubMed ID: 20590730
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanisms linking obesity to insulin resistance and type 2 diabetes.
    Kahn SE; Hull RL; Utzschneider KM
    Nature; 2006 Dec; 444(7121):840-6. PubMed ID: 17167471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.